Margaret Mason

Margaret Mason is the Head of GXP Quality at Strand Therapeutics. She brings three decades of pharmaceutical experience with the majority of her career working in a quality role including product quality oversight, implementation of quality systems and managing regulatory agency inspections. She is experienced with building quality programs and departments in both large and small pharma/biotech companies including Abbott Laboratories, Takeda, Shire and Surface Oncology. At Takeda, Margaret built and managed a team responsible for internal and external audits, regulatory agency inspections and product recalls. She received Takeda’s Outstanding Contributor of the year award two years in a row for her work in supplier qualification and recall management. Margaret’s position as Head of GXP Quality at a small biotech company, she utilized her hands-on approach building a GXP Quality organization. In this role Margaret applied Operational Excellence knowledge to map a path to expedited IND filings. Throughout her career, she has continued to develop her quality knowledge by completing course work required for Qualified Person and her management experience by completing the Harvard Manage Mentor, and risk management and courses. Margaret earned her Bachelor of Science focusing on microbiology and biotechnology at University of Illinois.